Clinical research

Patent coronary artery and myocardial infarction in the era of primary angioplasty: assessment of an old problem in a new setting with data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

EuroIntervention 2010;6:590-595.

Martin Kreutzer
Martin Kreutzer1*, MD; Anders Magnuson2, Bsc; Bo Lagerqvist3, MD, PhD; Ole Fröbert1, MD, PhD
1. Department of Cardiology, Örebro University Hospital, Örebro, Sweden; 2. Statistical and epidemiology unit, Örebro University Hospital, Örebro, Sweden; 3. Department of Cardiology, Uppsala University, Uppsala, Sweden

Aims: The purpose of this study was to evaluate factors that contribute to a patent IRA (infarct - related artery) and the prognostic impact of a patent IRA in patients with ST-elevation my

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

coronary angioplastyacute myocardial infarction prognosisocclusive diseasereperfusion therapyspontaneous reperfusion
Read next article
The cost effectiveness of primary angioplasty compared to thrombolysis in the real world: one year results from West London

Latest news